Peripheral giant cell granuloma associated with dental implants: a systematic review

dc.creatorBruno Ramos Chrcanovic
dc.creatorCarolina Cavaliéri Gomes
dc.creatorRicardo Santiago Gomez
dc.date.accessioned2025-08-18T21:53:04Z
dc.date.accessioned2025-09-09T01:10:10Z
dc.date.available2025-08-18T21:53:04Z
dc.date.issued2019-11
dc.format.mimetypepdf
dc.identifier.doihttps://doi.org/10.1016/j.jormas.2019.01.010
dc.identifier.issn2468-7855
dc.identifier.urihttps://hdl.handle.net/1843/84412
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofJournal of Stomatology, Oral and Maxillofacial Surgery
dc.rightsAcesso Restrito
dc.subjectDental implants
dc.subjectGranuloma, giant cell
dc.subjectRecurrence
dc.subjectPrevalence
dc.subjectJaw, edentulous
dc.subjectMandible
dc.subject.otherDental implant
dc.subject.otherGiant cell lesion or the jaw
dc.subject.otherNon-neoplastic proliferative lesions
dc.subject.otherPeripheral giant cell granuloma
dc.subject.otherComplications
dc.titlePeripheral giant cell granuloma associated with dental implants: a systematic review
dc.typeArtigo de periódico
local.citation.epage461
local.citation.issue5
local.citation.spage456
local.citation.volume120
local.description.resumoThe purpose of the present review was to integrate the available published data on peripheral giant cell granuloma (PGCG) associated with dental implants into a comprehensive analysis of its clinical/radiologic features. An electronic search was undertaken in February/2018 in three databases, looking for publications reporting cases of PGCGs associated with dental implants. Nineteen publications were included, reporting 37 implant-associated PGCG. These lesions are more prevalent in women, in mandible, and in posterior regions of the jaws. Both 'excision alone' and 'excision + curettage' presented high recurrence rates (40% and 31.3%, respectively). The etiology of implant-associated PGCG has not yet been determined. Despite the small number of cases reported, implant-associated PGCG shows a high recurrence rate (1/3) for a benign non-neoplastic lesion and sometimes it requires the removal of the associated implant in order to prevent further recurrences. This recurrence rate is not affected by curettage after excision.
local.identifier.orcidhttps://orcid.org/0000-0002-3460-3374
local.identifier.orcidhttps://orcid.org/0000-0003-1580-4995
local.identifier.orcidhttps://orcid.org/0000-0001-8770-8009
local.publisher.countryBrasil
local.publisher.departmentFAO - DEPARTAMENTO DE CLÍNICA
local.publisher.departmentICB - DEPARTAMENTO DE MORFOLOGIA
local.publisher.departmentICB - DEPARTAMENTO DE PATOLOGIA
local.publisher.initialsUFMG
local.url.externahttps://www.sciencedirect.com/science/article/pii/S2468785519300205?via%3Dihub

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: